# 5-Fluorouracil Combined With CoFactor (5-10 Methylenetetrahydrofolate) in Treating Advanced Breast Cancer Patients

> **NCT00434369** · PHASE2 · UNKNOWN · sponsor: **Mast Therapeutics, Inc.** · enrollment: 31 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** CoFactor (ANX-510)

## Key facts

- **NCT ID:** NCT00434369
- **Lead sponsor:** Mast Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-02
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 31 (ESTIMATED)
- **Last updated:** 2008-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00434369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00434369, "5-Fluorouracil Combined With CoFactor (5-10 Methylenetetrahydrofolate) in Treating Advanced Breast Cancer Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00434369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*